Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 4, 2011 - Issue
Submit an article Journal homepage
96
Views
8
CrossRef citations to date
0
Altmetric
Review

Role of 5-HT2C receptor gene variants in antipsychotic-induced weight gain

Tessa JM WallaceNeurogenetics Section, Center for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada
,
Clement C ZaiNeurogenetics Section, Center for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada
,
Eva J BrandlNeurogenetics Section, Center for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada
&
Daniel J MüllerNeurogenetics Section, Center for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, CanadaCorrespondence[email protected]
Pages 83-93 | Published online: 18 Aug 2011

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

John Lally, Fiona Gaughran, Philip Timms & Sarah R Curran. (2016) Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics. Pharmacogenomics and Personalized Medicine 9, pages 117-129.
Read now
Seenae Eum, Adam M. Lee & Jeffrey R. Bishop. (2016) Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations. Dialogues in Clinical Neuroscience 18:3, pages 323-337.
Read now

Articles from other publishers (6)

Yanisa Wannasuphoprasit, Stig Ejdrup Andersen, Maria J. Arranz, Rosa Catalan, Gesche Jurgens, Sanne Maartje Kloosterboer, Henrik Berg Rasmussen, Anjali Bhat, Haritz Irizar, Dora Koller, Renato Polimanti, Baihan Wang, Eirini Zartaloudi, Isabelle Austin-Zimmerman & Elvira Bramon. (2022) CYP2D6 Genetic Variation and Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis. Frontiers in Psychology 12.
Crossref
Jan Juřica. (2020) The influence of genetic and epigenetic factors as covariates of the tolerability and therapeutic response to olanzapine in the treatment of psychotic diseases. Klinická farmakologie a farmacie 34:2, pages 63-69.
Crossref
Alex T. Raben, Victoria S. Marshe, Araba Chintoh, Ilona Gorbovskaya, Daniel J. Müller & Margaret K. Hahn. (2018) The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment. Frontiers in Neuroscience 11.
Crossref
Steven C. Wyler, Caleb C. Lord, Syann Lee, Joel K. Elmquist & Chen Liu. (2017) Serotonergic Control of Metabolic Homeostasis. Frontiers in Cellular Neuroscience 11.
Crossref
Raymond R. MacNeil & Daniel J. Müller. (2016) Genetics of Common Antipsychotic-Induced Adverse Effects. Complex Psychiatry 2:2, pages 61-78.
Crossref
Amilton Dos Santos-Júnior, Taciane Barbosa Henriques, Maricilda Palandi de Mello, Osmar Henrique Della Torre, Lúcia Arisaka Paes, Adriana Perez Ferreira-Neto, Letícia Esposito Sewaybricker, Thiago Salum Fontana, Eloisa Helena Rubello Valler Celeri, Gil Guerra-Júnior & Paulo Dalgalarrondo. (2016) Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents. International Journal of Endocrinology 2016, pages 1-10.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.